IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1

Historical Holders from Q3 2020 to Q4 2024

CUSIP
46333XAH1
Type / Class
Debt / NOTE 1.500% 6/1
All holders as of December 31, 2024
Q4 2024
Principal, excl. options
162M
Holdings value
$181M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
15
Number of buys
2
Number of sells
-4
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1

Period Principal Value Change Price Investors
2024 Q4 $162M $181M -$5.36M $0.92 15
2024 Q3 $175M $155M -$26.7M $0.89 19
2024 Q2 $200M $188M -$1.53M $0.94 19
2024 Q1 $197M $201M -$4.54M $1.01 26
2023 Q4 $198M $215M -$57.8M $1.08 23
2023 Q3 $254M $235M +$47.1M $0.98 21
2023 Q2 $195M $199M -$3.82M $1.02 17
2023 Q1 $199M $200M +$3.86M $1.00 23
2022 Q4 $193M $212M +$3.26M $1.09 25
2022 Q3 $172M $168M -$19M $1.02 24
2022 Q2 $191M $198M -$2.93M $1.08 21
2022 Q1 $194M $219M -$1.59M $1.18 19
2021 Q4 $196M $214M -$9.01M $1.14 19
2021 Q3 $198M $243M +$25.8M $1.21 19
2021 Q2 $177M $216M +$8.63M $1.20 18
2021 Q1 $170M $196M -$3.4B $1.13 17
2020 Q4 $174M $189M +$1.15M $1.13 17
2020 Q3 $167M $164M +$164M $0.98 17